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Cryptococcus neoformans is an opportunistic fungal pathogen and a leading cause of fungal-infection-related fatalities, espe-
cially in immunocompromised hosts. Several virulence factors are known to play a major role in the pathogenesis of cryptococ-
cal infections, including the enzyme phospholipase B1 (Plb1). Compared to other well-studied Cryptococcus neoformans viru-
lence factors such as the polysaccharide capsule andmelanin production, very little is known about the contribution of Plb1 to
cryptococcal virulence. Phospholipase B1 is a phospholipid-modifying enzyme that has been implicated in multiple stages of
cryptococcal pathogenesis, including initiation and persistence of pulmonary infection and dissemination to the central nervous
system, but the underlying reason for these phenotypes remains unknown. Here we demonstrate that aplb1 knockout strain of
C. neoformans has a profound defect in intracellular growth within host macrophages. This defect is due to a combination of a
50% decrease in proliferation and a 2-fold increase in cryptococcal killing within the phagosome. In addition, we show for the
first time that theplb1 strain undergoes a morphological change during in vitro and in vivo intracellular infection, resulting in
a subpopulation of very large titan cells, which may arise as a result of the attenuated mutant’s inability to cope within the
macrophage.
Cryptococcus neoformans is a pathogenic fungus that can causesevere and often fatal meningoencephalitis, especially in im-
munocompromised hosts. In recent years, C. neoformans has be-
come a major emerging pathogen, due largely to the global HIV
pandemic. In sub-Saharan Africa, for example, C. neoformans
likely accounts for up to 44% of fatal HIV-related secondary in-
fections (1). During infection, C. neoformans is known to interact
closely with host macrophages (2) following inhalation of infec-
tious spores from the environment into the lungs (3). Many viru-
lence factors expressed byC. neoformans allow the fungus to evade
phagocytosis by macrophages or to improve survival once phago-
cytosed (4).
One such virulence factor is phospholipase B1 (Plb1), a phos-
pholipid-modifying enzyme with multiple enzymatic activities
(5). In cryptococcal cells, a significant proportion of Plb1 enzy-
matic activity is cell wall associated, although secretion of Plb1
from Cryptococcus is known to occur in vitro (6). Plb1 is secreted
following cleavage of a glycosylphosphatidylinositol (GPI) anchor
motif, which anchors the enzyme to the cell wall (7, 8), and export
of Plb1 to the cell wall is facilitated by Sec14-1, which is part of C.
neoformans’s protein export system (9). Plb1 has optimal activity
under acidic conditions, at around pH 4.0 to 5.0 (conditions sim-
ilar to that of the phagosome), and is active at 37°C (10).
In line with this putative role in pathogenesis, deletion of PLB1
strongly attenuates virulence in C. neoformans (9, 11–13). Mice
infected with a PLB1 deletion C. neoformans strain (plb1) show
reduced fungal burden in the lungs (9). In addition, during mu-
rine infection Plb1 appears to be required for cryptococcal dis-
semination from the lungs into the bloodstream (12) and addi-
tionally may be involved in the translocation of cryptococcal cells
across the blood-brain barrier into the brain (14).
The reason why theplb1 strain is attenuated during infection
has not yet been fully elucidated. In this study, we sought to ex-
plore the role of Plb1 during macrophage infection. We report
that Plb1 is critical for both proliferation and survival within the
macrophage. In addition, we show that the plb1 strain responds
to macrophage infection by significantly increasing both capsular
diameter and overall cell size within the phagosome and in the
murine lung. This morphology is reminiscent of previously re-
ported titan cells (15–17) and suggests that control of cryptococcal
cell size by Plb1 may play a vital role in the outcome of host mac-
rophage infection.
MATERIALS AND METHODS
Ethics statement. A total of 14 mice were handled in strict accordance
with good animal practice, as defined by the relevant national and/or local
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animal welfare bodies. All animal work was approved by the University of
Minnesota Institutional Animal Care and Use Committee (IACUC) un-
der protocol no. 1308A30852.
Strains, media, and cell lines. The strains used in this work are listed
in Table 1. Strains were stored long-term in MicroBank vials at 80°C.
Strains were rescued onto yeast extract-peptone-dextrose (YPD) agar
(YPD, 50 g/liter [Sigma-Aldrich]; 2% agar [Melford]) for 48 h at 25°C and
then stored until needed at 4°C. Before experimentation, liquid cultures
were grown from these stock plates in 2 ml YPD growth medium (50
g/liter) for 24 h at 25°C under constant rotation.
The J774murinemacrophage cell linewas used for all in vitro infection
assays. Cells were passaged in Dulbecco’s modified Eagle medium
(DMEM) culture media with serum (DMEM, low glucose, from Sigma-
Aldrich; 10% fetal bovine serum [FBS] from Invitrogen; 1% 10,000 units
penicillin–10 mg streptomycin from Sigma-Aldrich; 1% 200 mM L-glu-
tamine from Sigma-Aldrich). Assays were performed with J774 cells be-
tween passages 4 and 15. Assays were performed in serum-free DMEM
(DMEM [high glucose], 1% penicillin-streptomycin, 1% L-glutamine)
unless otherwise stated.
Intracellular proliferation assay.The intracellular proliferation assay
was performed as previously described (18). Briefly, 24 h before infection,
1  105 J774 macrophages were seeded onto 24-well plastic plates
(Greiner Bio One Cell Star) in 1 ml culture medium with serum and
incubated for 24 h at 37°C and 5% CO2. Before infection, J774 cells were
activated with 150 ng/ml phorbol 12-myristate 13-acetate in dimethyl
sulfoxide (DMSO; Sigma) in 1ml serum-free culturemedium for 45min.
This medium was then replaced with serum-free medium alone. Simul-
taneously, overnight C. neoformans cultures grown at 25°C in YPD were
washed three times in sterile 1 phosphate-buffered saline (PBS), quan-
tified, and adjusted to 1 107 cells per ml in PBS before opsonization for
1 h with 10 g/ml anticapsular 18B7 antibody (a kind gift from Arturo
Casadevall, Albert Einstein College of Medicine, New York, NY, USA).
The activated J774 cells were then infected with 100 l opsonized C. neo-
formans to give a multiplicity of infection (MOI) of 10 (e.g., 1 105 J774
cells for 1  106 C. neoformans cells) in unsupplemented serum-free
DMEM and incubated for 2 h at 37°C, 5% CO2. After 2 h (time point 0),
infected wells were washed at least 3 times with warm 1 PBS until all
nonphagocytosed C. neoformans cells were removed from the wells.
For calculation of the intracellular proliferation rate, the number of
internal cryptococci was determined at time points 0, 18, and 24 (time
points 0, 0  18 h, and 0  24 h, respectively). At each time point, each
well to be counted was washed three times with 1 PBS to remove any
extracellular yeast. The macrophages in the well were then lysed in dis-
tilled water for 30 min. C. neoformans cells in the lysate were quantified at
each time point with a cell-counting chamber, and the intracellular pro-
liferation rate (IPR) was calculated by dividing the count at which the
intracellular burden peaked by the count at time point 0. Viability testing
of the recovered cells was achieved by diluting the lysate to give a concen-
tration of 200 yeast cells per 100l and then plating ontoYPDagar at 25°C
for 48 h prior to counting CFU.
Phagocytosis assay. Twenty-four hours before assaying, J774 macro-
phages were seeded onto 13-mm glass coverslips (nitric acid treated) in-
side 2-cm2 24-well plates at a concentration of 1 105 cells per ml in 1ml
DMEM culture medium with serum and incubated at 37°C and 5% CO2.
Activation and infection of the macrophages with opsonized C. neofor-
mans cells followed the same protocol as described above for the intracel-
lular proliferation assay. After 2 h of incubation, the cells were washed 3
times with 1 PBS to remove unphagocytosed cells and then fixed for 10
minwith 250l 4%paraformaldehyde in PBS at 37°C. Following fixation,
coverslips were washed with 1 PBS and sterile deionized water and
mounted on glass slides using Mowiol mountant (100 mMTris-HCl [pH
8.5], 9% Mowiol, 25% glycerol). Mounted coverslips were analyzed on a
Nikon Ti-S inverted microscope fitted with a Plan apochromatic
(APO) 60  1.40 differential interference contrast (DIC) oil immer-
sion objective.
Cell size assay. J774 cells were plated into 24-well plates, activated, and
infected with opsonized C. neoformans strains as described above for the
IPR assay. Two hours postinfection, each well was washed at least 3 times
with warm 1 PBS until all nonphagocytosed C. neoformans cells were
removed from the wells, and 1 ml serum-free DMEM was then added to
each well.
The 24-well plate was placed into an environmentally controlled stage
(Okolabs) set to 30°C, 5% CO2. The cells were imaged using a Nikon
TE2000 microscope fitted with a Digital Sight DS-Qi1MC camera and a
PlanAPOPh1 20dry objective. Imageswere recorded every 4min for 20
h. Image acquisition and analysis was performed using the Nikon NIS
Elements software package (Nikon).
Cell size was measured using the ellipse area tool, measuring from the
center of eachCryptococcus cell to the edge, to obtain the diameter of each
cell.
In vivo titan cell and phagocytosis assay. Cryptococcus neoformans
cells were grown in YPD broth overnight. Cells were pelleted and resus-
pended in sterile phosphate-buffered saline at a concentration of 1 107
cells/ml based on hemocytometer count. Groups of 6- to 8-week-old fe-
male A/J mice (Jackson Laboratory, Bar Harbor, ME) were anesthetized
by intraperitoneal pentobarbital injection. Four to fivemice per treatment
were infected intranasally with 5  105 cells in 50 l PBS. At 3 days
postinfection,micewere sacrificed byCO2 inhalation. Lungswere lavaged
with 1.5 ml sterile PBS three times using a 18.5-gauge needle placed in the
trachea. Cells in the lavage fluid were pelleted and fixed in 3.7% formal-
dehyde at room temperature for 30min.Cells werewashed oncewith PBS,
and500 cells per animal were analyzed for size bymicroscopy (AxioIm-
ager, Carl Zeiss, Inc.). Cell body sizes were measured, and cells were clas-
sified as small cells (15m in cell body diameter) or titan cells (15m
in cell body diameter).
Titan cell flow cytometry.H99 was cultured in YPD broth overnight.
Cells were pelleted, washed three times in PBS, and fixed in 3% parafor-
maldehyde at room temperature for 10 min. Bronchoalveolar lavage
(BAL) samples were washed once in 0.05% sodium dodecyl sulfate (SDS)
to lysemammalian cells and thenwashed three times in sterile water. Cells
were pelleted and fixed in 3% paraformaldehyde at room temperature for
10 min. Following fixation, samples were washed with PBS, stained with
0.5 g/ml Hoechst (Sigma, St. Louis, MO) at room temperature for 10
min, washed again with PBS, and then resuspended in PBS. Approxi-
mately 10,000 cells were examined for cell size by forward scatter (FSC)
and for DNA content by Hoechst staining using an LSRII flow cytometer
with FACSDiva software (BD Biosciences, San Jose, CA). Graphs were
generated using Flowjo software (Tree Star, Inc., Ashland, OR). The t test
was used to analyze the differences in titan cell formation and phagocyto-
sis, and P values of0.05 were considered significant.
Cell stress.OvernightC. neoformans cultures in 2ml YPDwere grown
at 25°C. Cultures were diluted 1:1,000 into 500 l buffered YPD (pH 7.0,
15mMHEPES) in plastic-bottomed 48-well plates (Greiner) with various
concentrations of SDS (0, 0.01, 0.05, 0.1, 0.25, and 0.5 mM), of H2O2 (0,
0.125, 0.25, 0.5, 1, 3, 6, and 14 mM), or of NaCl (0, 125, 250, 500, 1,000
mM). The plate was then sealed with a breathable membrane, and growth
curve assays were performed for 24 h at 30°C in a Fluostar Omega plate
reader using a custom script that took 600-nm absorbance readings from
TABLE 1 Strains used in this study
Strain or
genotype Description Reference
H99 C. neoformans serotype A mating type 	; wild-
type parent strain
plb1 PLB1 gene knockout 10
plb1::PLB1 plb1 strain with PLB1 gene reconstituted 10
sec14 SEC14-1 gene knockout 13
sec14::SEC14 sec14 strain with SEC14-1 gene reconstituted 13
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the bottom of the plate every 30 min. Between reads, the plate was shaken
at 200 rpm with a linear shaking pattern.
Statistics. Unless otherwise stated, all statistics were performed using
Prism Graphpad software. For cell size measurement comparison be-
tween time points, aMann-Whitney U test was performed (e.g., StrainX 0
h versus StrainX 18 h). Unless stated otherwise, a P value below 0.05 was
taken as significant. Unless otherwise stated, all figures have error bars
representing standard errors. Significance is shown on figures by asterisks
as follows: *, P 0.05; **, P 0.01; ***, P 0.001; and ****, P 0.0001.
RESULTS
Plb1 deficiency leads to increased uptake ofC. neoformans cells
by J774 macrophages. We first assessed to what extent the PLB1
knockout strain, plb1 strain, was phagocytosed by macrophages
in comparison to thewild-type parent strainH99 and a genetically
reconstituted strain,plb1::PLB1 strain.We found that, following
2 h of infection, the percentage of J774 murine macrophages with
at least one internalized C. neoformans cell did not differ signifi-
cantly between wild-type strain H99, plb1 strain, and plb1::
PLB1 reconstituted strain (Fig. 1A). Quantification of the fungal
burden permacrophage, however, revealed a 2-fold increase in the
number of plb1 cells phagocytosed per host cell (Fig. 1B, P 

0.0003). This suggests that Plb1 activity contributes significantly
to the well-known antiphagocytic phenotype of cryptococci.
Plb1 is required for intracellular proliferation of C. neofor-
mans within J774 macrophages. PLB1 knockout leads to a re-
duced fungal lung burden duringmurine infection; in addition, it
abrogates dissemination to the brain (9, 14) and has previously
been shown to reduce budding of C. neoformans within macro-
phages (11). To investigate this phenotype further, we performed
an intracellular proliferation rate assay. We observed an intracel-
lular proliferation defect for the plb1 strain versus the wild-type
strain (IPR 
 1.12 versus 2.42 for H99; P 
 0.023), a defect that
was fully restored in the plb1::PLB1 reconstituted strain (Fig.
2A). Interestingly, no intracellular proliferation defect was ob-
served when we tested thesec14 strain (Fig. 2A). Since Sec14-1 is
required for efficient secretion of Plb1 (9), it appears that intracel-
lular, but not secreted, Plb1 is important for proliferation within
host cells.
Due to the increased efficiency of plb1 cell uptake observed,
we wondered whether the reduced proliferation we see for plb1
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FIG 1 (A) Percentages of macrophages within a population that show C. neoformans infection following 2-h incubation with opsonized cryptococci at an MOI
of 1:10 (n
 4). Aminimumof 500macrophageswere counted for each condition. (Unpaired t test was performed, no significance.) (B) Total burden of infection
within a fixed population of J774 cells (1 105) following 2-h incubation with opsonized cryptococci at an MOI of 1:10 (n
 9). ***, H99 versus plb1 strain,
P
 0.0003; **, plb1 versus plb1::PLB1 strains, P
 0.0038 (unpaired t test).
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FIG 2 (A) Mean intracellular proliferation rate for each C. neoformans strain within murine J774 macrophages (n
 3). *, H99 versus plb1 strain, P
 0.023;
*, plb1 versus plb1::PLB1 strains, P
 0.033; *, plb1 versus sec14::SEC14 strains, P
 0.0263 (one-way analysis of variance [ANOVA] plus Tukey posttest).
(B) Viability of C. neoformans cells recovered from J774 macrophages following the IPR assay. Cells recovered following macrophage lysis were counted and
diluted, giving an expected plated inoculum of 200 cells (n
 4). *, plb1 strain 0 h versus plb1 strain 18 h, P
 0.0422; *, plb1 strain 0 h versus plb1 strain
24 h, P
 0.0415 (two-way ANOVA plus Tukey posttest comparing time points for each strain).
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cells simply reflects initial overcrowding within the host macro-
phage. To test this, we reduced the uptake of plb1 cells by omit-
ting the opsonization step before infection. Infecting with unop-
sonized Cryptococcus reduced uptake for all three strains (see Fig.
S1Ci in the supplemental material: unopsonized Cryptococcus can
still be phagocytosed by macrophage but at a lower rate [19, 20])
but did not alter the growth defect observed (see Fig. S1Cii in the
supplemental material). To test a different method of opsoniza-
tion, we also tried opsonizing with pooled serum instead of anti-
body. At the concentration used (5% pooled human serum), we
did not see significant differences in uptake, compared to anti-
body opsonization (see Fig. S1Bi in the supplemental material),
and the proliferation defect remained (see Fig. S1Bii in the sup-
plemental material). Taken together, these data suggest that Plb1
plays a direct role in regulating intracellular proliferation in cryp-
tococci regardless of the fungal intracellular burden.
Plb1 contributes toC. neoformans cell survival during infec-
tion. The low intracellular proliferation defect observed forplb1
could be due to slowerCryptococcusproliferation and/or increased
intracellular killing by the macrophage. To address the second
possibility, we plated C. neoformans cells recovered from macro-
phages at 18 and 24 h postinfection on YPD agar to enumerate
CFU. No significant difference in CFU among any of the five
strains was seen at time point 0 (2 h postinfection); however, at
time point 18 (20 h postinfection), the viability ofplb1 strain but
not that of the sec14-1 strain had dropped significantly (P 

0.04) (Fig. 2B) compared to that of H99. Taken together, these
data suggest that both growth and survival of the plb1 strain are
impaired within the phagosome during macrophage infection.
Plb1 deficiency does not significantly affect cryptococcal
stress responses. We hypothesized that low IPR in the macro-
phage may be a result of stressful conditions during macrophage
infection—possibly because the plb1 strain is unable to control
or resist cellular stresses within the macrophage. However, expos-
ing the plb1 strain to a variety of stresses showed no significant
difference from the wild type other than the previously reported
susceptibility to SDS (9) (Fig. 3A and B).
PLB1 knockout leads to changes in cryptococcal cell body
morphology. During the course of this work, we noticed that
some plb1 cells showed a marked increase in cell body diameter
within infected macrophages, a morphology that was not ob-
served for H99 or the plb1::PLB1 strain (Fig. 4E and F). Quanti-
fication of this phenomenon (Fig. 4) showed that the diameter of
both the cell body and the capsule of plb1 cells increased signif-
icantly during an 18-hmacrophage infection (Fig. 4A to E). Inter-
estingly, we observed a significant decrease in cell diameter for
H99 and plb1::PLB1 cells over the same incubation period (see
Table S1 in the supplemental material), which is probably due to
active cell budding occurring within the macrophage, leading to a
drop in mean diameter for the overall population. Extending the
period of live cell imaging to 48 h, we found that the enlarged
plb1 cells did not noticeably increase in size after 18 h postinfec-
tion.
Changes in Cryptococcus cell size during in vivo infection have
been previously documented, ultimately resulting in the produc-
tion of very large titan cells (15–17, 21). To our knowledge,
though, this is the first published observation of a similar (albeit
less dramatic) process occurring within a macrophage (rather
than extracellularly) and the first time that PLB1 has been impli-
cated in this pathway. Previous studies have reported that the size
increase observed in titan cells is accompanied by increased nu-
clear content due to polyploidy (15, 16). In agreement with this,
flow cytometric analysis of plb1 cells following macrophage in-
fection demonstrated a positive correlation between cell size and
DNA quantity (Fig. 5A), indicating increased nuclear content
within these cells.
plb1 cells have a higher rate of titan cell formation than do
wild-type cells during in vivomurine infection.Our in vitro ob-
servation of plb1 cell enlargement was reminiscent of the titan
cell morphology observed during in vivo murine pulmonary in-
fection (15, 16, 21). To test whether this phenotype was recapitu-
lated in vivo, we conducted pulmonary infections inmice and then
quantified cryptococcal size following bronchoalveolar lavage
(BAL) at 3 days postinfection. As with our in vitro data, in vivo
infection with plb1 cells produced about 2.5 times more titan
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cells (cryptococci with a cell body diameter greater than 15 m)
than H99 or plb1::PLB1 cells (Fig. 6Ai). Flow cytometry of la-
vaged, Hoechst-stained plb1 titan cells indicated that these cells
are polyploid, in agreement with previously published character-
ization of titan cells (15, 16) as well as our own in vitro observation
ofplb1 cells (Fig. 5A). Taken together, these findings suggest that
themorphological changes that we observed in ourplb1 cells are
consistent with an increase in the production of titan cells by this
strain both in vitro and in vivo.
In vivo plb1 titan cell formation is not associated with
phagocytosed cells. In addition to quantifying overall titan cell
formation in BAL samples, we also counted the Cryptococcus cells
within host phagocytes following BAL andmeasured the cell body
diameter of each Cryptococcus cell within each lavaged host cell.
We found that there were significantly fewer lavaged host cells
containing Cryptococcus for plb1 strain-infected mice than for
mice infected with H99 or plb1::PLB1 strain (Fig. 6Aii, H99 ver-
sus plb1, P 
 0.0001; plb1 versus plb1::PLB1, P 
 0.0018).
FIG 4 (A toD)C. neoformans cells weremeasured after either 18 h inside J774macrophages or 18 h in serum-free DMEM. The top and bottom of each boxmark
the 75th and 25th percentiles, respectively, the bisecting line in the boxmarks themedian, and the two whiskers mark themaximum andminimum of the range.
Mann-Whitney U tests were performed for each time point pair. Full statistical results are given in Tables S1 and S2 in the supplemental material. (B) Capsule
thickness was calculated by subtracting cell body diameter from total diameter including capsule. (D) The ratio of cell body to capsule was calculated by dividing
cell body diameter by capsule thickness. (E) Still bright-field images from live-cell microscopy following the same macrophage over 18 h for H99, plb1, and
plb1::PLB1 strains. Black arrows indicate the location of singleC. neoformans cells within themacrophage. (F) Still bright-field images from live-cellmicroscopy
following viable plb1 strain-infected macrophages. Images were taken at 40 h postinfection; bar, 10 m.
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FIG 5 (A) Flow cytometric analysis of C. neoformans samples pre- and postincubation with J774 macrophages (18 h). Samples were stained with Hoechst to
quantifyDNAcontent; FSC-A (forward scatter area) indicates the relative cell size across the samples. Cells were gated based on size and nuclear contentwith cells
inQ3 consistentwith small cells inG1, cells inQ4 indicative of small cells inG2, and cells inQ2 indicative of polyploidy titan cells with both large size and increased
DNA content. (B) Mean percentage of total events (10,000 collected) across 3 repeats occurring in the Q2 gate. A one-tailed t test was performed for H99 and
plb1 strains as well as plb1and plb1::PLB1 strains to determine if the increase in events within the Q2 gate observed was significant: *, H99-infected versus
plb1 strain-infected cells, P
 0.034; *,plb1 strain-infected versusplb1::PLB1 strain-infected cells, P
 0.015; **,plb1 strain-uninfected versusplb1::PLB1
strain-uninfected cells, P
 0.001.
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Very fewof these internalizedCryptococcus cells were above 10m
in diameter, and those that were above 10 m could be found in
similar numbers for H99, plb1, and plb1::PLB1 cells (Fig.
6Aiii). No cells greater than 15 mwere found inside phagocytes
in either the control or the plb1 strain infections (data not
shown). This leads us to conclude that in vivo plb1 titan cell
formation potentially occurs initially within host cells (as we ob-
serve in vitro) but these large cryptococci are released from host
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FIG 6 In vivo titan cell assay on Cryptococcus cells lavaged from mouse lungs 3 days postinfection. (Ai) A minimum of 500 cells per animal were analyzed to
quantify cell body diameter, Cryptococcus cells 15 m in diameter were considered titan cells (***, H99 versus plb1 strain, P 
 0.0001; ***, plb1 versus
plb1::PLB1 strains,P
 0.0018 [two-tailed unpaired t test]). (Aii)Host cells lavaged from the lungswere examined for phagocytosedCryptococcus cells (***,H99
versus plb1 strain, P
 0.0001; ***, plb1 versus plb1::PLB1 strains, P
 0.0001 [two-tailed unpaired t test]). (Aiii) The cell body diameter of phagocytosed
Cryptococcus cells within lavaged host macrophages was quantified, and data for phagocytosed cells10m are given. (B) Bronchoalveolar lavage samples with
Cryptococcus fromH99 andplb1 strains were stainedwithHoechst and analyzed for size and nuclear content. Cells were gated based on size and nuclear content
with cells in Q3 consistent with small cells in G1, Q4 indicative of small cells in G2, and Q2 indicative of polyploidy titan cells with both large size and increased
DNA content. (C) Bright-field images of lavaged cells from H99, plb1, or plb1::PLB1 strain-infected lungs. Bar, 15 m.
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cells either by host cell lysis in vivo or due to the physical process of
lavage prior to the time point examined.
DISCUSSION
During cryptococcal pathogenesis, C. neoformans interacts with
professional phagocytes in the alveolar space (2), in the blood-
stream, and in other tissues following dissemination. The out-
come of this interaction appears to be vital for disease progression,
as themacrophage provides a protective niche for replication (18)
and a potential “Trojan horse” for dissemination to the central
nervous system (22, 23). Together with previous studies, our find-
ings strongly suggest that expression of Plb1 is critical in regulat-
ing cryptococcus-macrophage interactions.
First, we show that PLB1 deletion leads to enhanced uptake by
phagocytes in vitro (Fig. 1B). Since Plb1 is a GPI-linked, cell wall-
associated protein (7), it is likely that loss of this enzyme affects the
cryptococcal cell surface and, presumably, this change facilitates
more-efficient binding of phagocyte receptors. Examination of
different opsonization methods (see Fig. S1 in the supplemental
material) suggests that increased uptake is due to a combination of
antibody, complement, and nonopsonic ligands. Cryptococcal
cell wall instability following PLB1 deletion has been published
previously (8), and thus this instability could lead to increased
ligand exposure on the Cryptococcus cell surface. In light of these
observations, a detailed chemical analysis of the cell surface com-
position in this strain would be of considerable future interest.
Following phagocytosis, we find that C. neoformans requires
the expression of Plb1 to proliferate and survive normally within
the macrophage (Fig. 2). This finding provides a mechanism to
explain previous reports of reduced fungal burdens following in-
fection with plb1 cells (9). Interestingly, however, the sec14-1
strain shows no such defect in intracellular proliferation. Since
this strain shows strongly reduced Plb1 secretion (9), the most
likely explanation is that the primary role of Plb1 in driving intra-
cellular proliferation is in themetabolism of fungal phospholipids
within the cryptococcal cell, rather than in acting directly upon
host phospholipids. However, secreted Plb1 appears to have addi-
tional roles in virulence, since the sec14-1 strain is attenuated in
animal models (9). It is tempting to speculate that the docu-
mented involvement of SEC14 in regulating vomocytosis (9) may
be one such role.
A strikingmorphological observation arising from ourmacro-
phage infection model was that plb1 cells showed a marked in-
crease in both cell body diameter and capsule thickness during
infection, with a maximum measured diameter (including cap-
sule) of almost 25m(Fig. 4C). That this size change was not seen
in the wild-type orplb1::PLB1 reconstituted strains suggests that
this morphology results from the loss of Plb1. Previously reported
titan cells grown in vivo range in diameter from 15 to 100 m,
excluding the capsule (15, 16). Therefore, the size increase that we
observed is smaller than that of previously reported titan cells but
significantly larger than the normal cryptococcal size range.
Interestingly, previous reports of titan cells induced in vitro
also noted that the cells tended to be smaller than those gener-
ated in vivo (16). Flow cytometry analysis of plb1 cells follow-
ing macrophage infection (Fig. 5) indicates that the large cells
show increased DNA content, consistent with the defining fea-
ture of titan cells (16). Thus, these cells may represent individ-
ual yeast cells that are “en route” to becoming Titan cells or
have somehow been constrained by the macrophage, or it may
be that the in vitro conditions do not provide the necessary
stimulus to produce the largest titan cells.
Fromour in vitro data, we conclude that theplb1 strain forms
large cells within macrophages, which are similar to the titan cell
morphology seen in vivo. Titan cell formation has previously been
induced in vitro usingmacrophage-conditionedmedia (16); how-
ever, titan cell formation induced inside an infected macrophage
has to our knowledge not previously been reported. Although we
have not identified the trigger for this morphology, it is evidently
linked to Plb1 deficiency. The development of this morphology
within the macrophage may be a response to increased stress ex-
perienced by the plb1 strain, as indicated by the decreased via-
bility of this strain within the phagosome. Although we did not
detect any significant difference stress tolerance for plb1 organ-
isms in vitro, other than the previously published susceptibility to
SDS (9), growth within the phagosome exposes cryptococci to a
diverse repertoire of additional stresses, and it is likely that these
complex conditions limit the growth of this mutant. One possible
source of stress within the phagosome, which links our observed
phenotypes, is the observation that in wild-type cryptococci, Plb1
concentrates at the neck of newly forming buds (24). This suggests
that Plb1 may have a role in bud development, and thus it is
conceivable that modification of membrane phospholipids by
Plb1 during budding could be required for membrane curvature
at the newly formed bud site or release of the daughter cell. The
inability of the plb1 strain to properly bud would explain the
proliferation defect observed and could generate sufficient cellular
stress to reduce cryptococcal viability and trigger the development
of titan-like cells.
A strong link between our in vitro observations and previously
published in vivo development of titan cells is supported by our
finding that the plb1 strain forms greater numbers of “classical”
titan cells (i.e., cell body diameter above 15 m and high nuclear
content indicative of polyploidy) in vivo than do thewild-type and
reconstituted strains (Fig. 6Ai). These data suggest that Plb1 ac-
tivity is involved in the repression of titan cell formation during
infection. In addition, the fact that the sec14-1 strain does not
manifest similar cell size increases during in vitro infection (our
unpublished data) indicates that intracellular rather than extracel-
lular Plb1 activity regulates the titan cell morphology. Interest-
ingly, titan cell development may be linked to phospholipid avail-
ability (25), suggesting a potential link to Plb1 activity. Titan cell
formation in vivo has been reported to increase the pathogenicity
ofC. neoformans (16, 17); our conclusion that theplb1 strain has
increased titan cell formation therefore seems at odds with the in
vitro data presented in Fig. 1 and 2 showing that theplb1 strain is
attenuated in macrophages. It is therefore possible that the large
plb1 cells may not exhibit all the features of titan cells (for in-
stance, in conferring “cross-protection” on nontitan cells in the
same host). Alternatively, it may be that full pathogenicity re-
quires only a minor titan cell population and hence, the enhanced
titan cell frequency seen in the plb1 strain actually reduces over-
all virulence.
In summary, our data indicate that Plb1 plays a key role both in
intracellular survival within host phagocytes and in driving cryp-
tococcal cell size changes both in vitro and in vivo.
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